Tin tức & Cập nhật
Xem bài viết Dược
Xem
Chỉ hiển thị Multimedia

Tildrakizumab eases itch, improves life quality in scalp psoriasis
27 Jun 2024
bởiStephen Padilla
Treatment with tildrakizumab in patients with moderate-to-severe scalp psoriasis helps reduce scalp itch and improve quality of life when compared with placebo, with no new safety signals, as shown in a phase IIIb study.
Tildrakizumab eases itch, improves life quality in scalp psoriasis
27 Jun 2024
Statin-ezetimibe combo superior to monotherapy in preventing CVD in T2D patients
27 Jun 2024
In patients with type 2 diabetes (T2D), moderate-intensity statin in combination with ezetimibe results in greater reductions in low-density lipoprotein cholesterol (LDL-C) and better prevention of adverse outcomes when compared with high-intensity statin monotherapy, suggests a study.
Statin-ezetimibe combo superior to monotherapy in preventing CVD in T2D patients
27 Jun 2024
Off-label targeted drugs improve survival in CTEPH
26 Jun 2024
Off-label pulmonary arterial hypertension (PAH)-targeted drugs may increase long-term survival in patients with chronic thromboembolic pulmonary hypertension (CTEPH), as shown in a study.






